Manufacturer record
Infallible Pharma Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Infallible Pharma Pvt. Ltd (Maharashtra) were declared Not of Standard Quality between December 2023 and January 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: VIN 24011, Iron Sucrose Injection USP 20mg/ml (exp Jan 2026). DTL Thiruvananthapuram (state lab) found it not of standard quality: sample fails the tests 'Content of Chloride and pH as per USP, as specified in the Laboratory Protocol. Listed in the January 2026 alert.
Records by type
2 records linked to Infallible Pharma Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Iron Sucrose Injection USP 20mg/ml | Batch VIN 24011Mfg Feb 2024 · Exp Jan 2026 | sample fails the tests 'Content of Chloride and pH as per USP, as specified in the Laboratory Protocol.pH | DTL ThiruvananthapuramState lab | Jan 2026 |
| Heparin Sodium Injection IP 5000 IU/5ml,(INFA-HEP) | Batch A23LV060BMfg May 2023 · Exp Apr 2025 | pH, Particulate Matter and DescriptionDescription | CDL KolkataCDSCO lab | Dec 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.